Abstract:Background: In the United States, both drug overdose mortality and injection-involved drug overdose mortality have increased nationally over the past 25 years. Despite documented geographic differences in overdose mortality and substances implicated in overdose mortality trends, injection-involved overdose mortality has not been summarized at a subnational level. Objective: We aimed to estimate the annual number of injection-involved overdose deaths in each US state from 2000 to 2020. Methods: We conducted a stratified analysis that used data from drug treatment admissions (Treatment Episodes Data Set–Admissions; TEDS-A) and the National Vital Statistics System (NVSS) to estimate state-specific percentages of reported drug overdose deaths that were injection-involved from 2000 to 2020. TEDS-A collects data on the route of administration and the type of substance used upon treatment admission. We used these data to calculate the percentage of reported injections for each drug type by demographic group (race or ethnicity, sex, and age group), year, and state. Additionally, using NVSS mortality data, the annual number of overdose deaths involving selected drug types was identified by the following specific multiple-cause-of-death codes: heroin or synthetic opioids other than methadone (T40.1, T40.4), natural or semisynthetic opioids and methadone (T40.2, T40.3), cocaine (T40.5), psychostimulants with abuse potential (T43.6), sedatives (T42.3, T42.4), and others (T36-T59.0). We used the probabilities of injection with the annual number of overdose deaths, by year, primary substance, and demographic groups to estimate the number of overdose deaths that were injection-involved. Results: In 2020, there were 91,071 overdose deaths among adults recorded in the United States, and 93.1% (84,753/91,071) occurred in the 46 jurisdictions that reported data to TEDS-A. Slightly less than half (38,253/84,753, 45.1%; 95% CI 41.1%-49.8%) of those overdose deaths were estimated to be injection-involved, translating to 38,253 (95% CI 34,839-42,181) injection-involved overdose deaths in 2020. There was large variation among states in the estimated injection-involved overdose death rate (median 14.72, range 5.45-31.77 per 100,000 people). The national injection-involved overdose death rate increased by 323% (95% CI 255%-391%) from 2010 (3.78, 95% CI 3.33-4.31) to 2020 (15.97, 95% CI 14.55-17.61). States in which the estimated injection-involved overdose death rate increased faster than the national average were disproportionately concentrated in the Northeast region. Conclusions: Although overdose mortality and injection-involved overdose mortality have increased dramatically across the country, these trends have been more pronounced in some regions. A better understanding of state-level trends in injection-involved mortality can inform the prioritization of public health strategies that aim to reduce overdose mortality and prevent downstream consequences of injection drug use.

County by county estimation of deaths averted, infections averted, and cost savings of overdose prevention health centers in the United States

Economic evaluations of establishing opioid overdose prevention centers in 12 North American cities: a systematic review

Overdose prevention activities led by local public health departments, 2019–2023

Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City

Overdose Prevention Centers, Crime, and Disorder in New York City

Overdose deaths before and during the COVID-19 pandemic in a US county

Overdose prevention centers: Innovative strategy or federal law violation?

Heavy burden of non-fatal overdose among people who inject drugs in San Francisco, 2022

Systematic review and meta-analysis to estimate the burden of non-fatal and fatal overdose among people who inject drugs living in the U.S. and comparator countries: 2010 - 2023.

Virtual overdose monitoring services/mobile overdose response services: estimated number of potentially averted drug poisoning fatality events by various telephone and digital-based overdose prevention/harm reduction services in North America

A cost benefit analysis of a virtual overdose monitoring service/mobile overdose response service: the national overdose response service

Estimated Number of Injection-Involved Overdose Deaths in US States From 2000 to 2020: Secondary Analysis of Surveillance Data

Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial

Simulating the simultaneous impact of medication for opioid use disorder and naloxone on opioid overdose death in eight New York counties

Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis

Missed Opportunities for Preexposure Prophylaxis Initiation in Hospitalized Persons With Opioid Use Disorder and Infectious Diseases

Equitable Data-Driven Facility Location and Resource Allocation to Fight the Opioid Epidemic

A simple heuristic for allocating opioid settlement funding to reduce overdose mortality in the United States

Naloxone vending machines in county jail

Acceptability of Overdose Prevention Sites in the Business Community in Baltimore, Maryland

Examining the spatial risk environment tied to the opioid crisis through a unique public health, EMS, and academic research collaborative: Lowell, Massachusetts, 2008-2018